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We describe a family with strong family history of cardiomyopathy. The mother has 
dilated cardiomyopathy with symptoms onset around 40 years old requiring treatment for 
both heart failure and atrial fibrillation. She does not have muscle weakness and her 
creatine kinase level was normal. The elder son has hypertrophic cardiomyopathy with 
symptoms onset at 20 years old, a mildly elevated creatine kinase of 1000 U/L but no 
muscle weakness. The younger brother with limited intelligence was asymptomatic all 
along. At the age of 15 with an incidental finding of raised serum transaminase levels he 
was referred for further investigations. Initial consultation confirmed mild proximal 
weakness, calves hypertrophy, creatine kinase up to 3500 U/L and echocardiogram 
confirmed hypertrophic cardiomyopathy. Needle electromyography showed myotonia 
after ice application. Nerve conduction study with short exercise test showed compound 
muscle action potentials decrement confirming myotonia. Metabolic workup, DMD gene 
and CTG repeat mutation study were all negative. The muscle biopsy of the elder brother 
showed vacuolar myopathy. Subsequent LAMP2 mutation study on exome sequencing 
confirmed Danon Disease. Mother has subsequently undergone heart transplantation, and 
vacuolar myocytes are noted in the cardiac muscles. This report describe a family with 
Danon disease, a rare X-linked dominant condition, but an important differential 
diagnosis for patient with cardiomyopathy, myopathy and learning difficulty, having a 
strong family history of cardiomyopathy. While skeletal muscles biopsy showed vacuolar 
myopathy, these abnormal vacuolar changes also extended to the cardiac muscles. 
Diagnostic confirmation is important when counseling the long term prognosis for this 
family. While symptomatic treatment is available for the heart failure, with a progressive 
course of cardiomyopathy the ultimate cure is heart transplantation. 
